These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 9253384)

  • 1. On reaching the tunnel at the end of the light.
    Horwitz RI; Singer BH; Makuch RW; Viscoli CM
    J Clin Epidemiol; 1997 Jul; 50(7):753-5. PubMed ID: 9253384
    [No Abstract]   [Full Text] [Related]  

  • 2. On wisdom after the event.
    Senn S; Harrell F
    J Clin Epidemiol; 1997 Jul; 50(7):749-51. PubMed ID: 9253383
    [No Abstract]   [Full Text] [Related]  

  • 3. Within trial variation--a false trail?
    Altman DG
    J Clin Epidemiol; 1998 Apr; 51(4):301-3. PubMed ID: 9539885
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of carvedilol on outcome after myocardial infarction in patients with left ventricular dysfunction: the CAPRICORN randomized trial].
    Costalunga A; Gavazzi A
    Ital Heart J Suppl; 2001 Nov; 2(11):1246-7. PubMed ID: 11775420
    [No Abstract]   [Full Text] [Related]  

  • 5. The enrichment window approach as a means of dealing with placebo response in antidepressant clinical trials.
    Mallinckrodt CH; Prucka WR
    Clin Pharmacol Ther; 2010 Nov; 88(5):592-4. PubMed ID: 20959845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating effects of treatment in subgroups of patients within a clinical trial: the case of non-Q-wave myocardial infarction and beta blockers.
    Yusuf S; Wittes J; Probstfield J
    Am J Cardiol; 1990 Jul; 66(2):220-2. PubMed ID: 1973589
    [No Abstract]   [Full Text] [Related]  

  • 7. Beta-blockers and myocardial infarction: infarction and ischaemia in the practolol and propranolol trials.
    Green KG; Baber NS; Lewis JA
    Aust N Z J Med; 1983 Apr; 13(2):181-2. PubMed ID: 6137206
    [No Abstract]   [Full Text] [Related]  

  • 8. Can treatment that is helpful on average be harmful to some patients? A study of the conflicting information needs of clinical inquiry and drug regulation.
    Horwitz RI; Singer BH; Makuch RW; Viscoli CM
    J Clin Epidemiol; 1996 Apr; 49(4):395-400. PubMed ID: 8621989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The EMPHASIS-HF study].
    Boccanelli A; Agostoni P
    G Ital Cardiol (Rome); 2011 May; 12(5):315-8. PubMed ID: 21593949
    [No Abstract]   [Full Text] [Related]  

  • 10. Beta blockers in acute myocardial infarction.
    Jariwala PV; Lathi P; Ramesh G; Saha D; Chandra KS
    Indian Heart J; 2010; 62(2):148-53. PubMed ID: 21180308
    [No Abstract]   [Full Text] [Related]  

  • 11. beta-Adrenergic blocking agents in the post-myocardial infarction patient.
    Goldstein S
    Arch Intern Med; 1979 Oct; 139(10):1089-90. PubMed ID: 39535
    [No Abstract]   [Full Text] [Related]  

  • 12. [Beta-receptor blockers after revascularization in coronary sclerosis].
    Osterziel KJ
    Dtsch Med Wochenschr; 1995 Sep; 120(37):1258-9. PubMed ID: 7671786
    [No Abstract]   [Full Text] [Related]  

  • 13. Beta-blockers in immediate treatment of myocardial infarction.
    Br Med J; 1980 Jun; 280(6231):1619. PubMed ID: 6107144
    [No Abstract]   [Full Text] [Related]  

  • 14. Prophylactic use of beta-adrenergic blockade in survivors of myocardial infarction.
    Rotmensch HH; Vlasses PH; Ferguson RK
    Heart Lung; 1984 Jul; 13(4):366-71. PubMed ID: 6145686
    [No Abstract]   [Full Text] [Related]  

  • 15. Beta-blockers after myocardial infarction.
    Med Lett Drugs Ther; 1979 Dec; 21(25):101. PubMed ID: 44732
    [No Abstract]   [Full Text] [Related]  

  • 16. Interim analysis: the alpha spending function approach.
    DeMets DL; Lan KK
    Stat Med; 1994 Jul 15-30; 13(13-14):1341-52; discussion 1353-6. PubMed ID: 7973215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new population-enrichment strategy to improve efficiency of placebo-controlled clinical trials of antidepressant drugs.
    Merlo-Pich E; Alexander RC; Fava M; Gomeni R
    Clin Pharmacol Ther; 2010 Nov; 88(5):634-42. PubMed ID: 20861834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COMMIT/CCS-2 studies.
    Garton M
    Lancet; 2006 Aug; 368(9536):642; author reply 642-3. PubMed ID: 16920459
    [No Abstract]   [Full Text] [Related]  

  • 19. Beta adrenoceptor blockade in acute myocardial infarction.
    Norris RM
    Am Heart J; 1980 Jun; 99(6):683-5. PubMed ID: 6103669
    [No Abstract]   [Full Text] [Related]  

  • 20. Designing multiregional trials under the discrete random effects model.
    Lan KK; Pinheiro J; Chen F
    J Biopharm Stat; 2014; 24(2):415-28. PubMed ID: 24605977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.